Literature DB >> 30178544

Lymphoma survivors' experiences at the end of treatment.

Fidelma Hackett1, Maura Dowling2.   

Abstract

AIMS AND
OBJECTIVES: To explore lymphoma survivors' experiences on their end of treatment and follow-up care at a large urban haematology centre in Ireland.
METHODS: This was a qualitative study using semistructured interviews with lymphoma patients post-treatment (n = 14). Thematic analysis guided the analysis of interview data. The study adhered to the consolidated criteria for reporting qualitative research (COREQ) guidelines.
FINDINGS: Five main themes were identified following analysis of the interview data: dealing with uncertainty, changed relationships, returning to work, extended recovery time and concerns for the future. Findings of note were that some participants were unaware that their treatment had ended, many experienced recurrent infections which prolonged recovery time, and many had no recall of discussions on healthy lifestyle behaviours or recommended screening programmes at their follow-up visits.
CONCLUSIONS: The findings suggest that the period of transition from active treatment to survivorship can be challenging for lymphoma survivors, and they experience ongoing needs. While the challenges of survivorship in lymphoma mirror those of other cancers, this cohort of patients require focused preparation for the end of active treatment and the transition to follow-up care. Moreover, this patient group requires repeated specific education on late effects and second cancers, education with regards to identifying the signs of cancer recurrence and promotion of healthy lifestyle practices. RELEVANCE TO CLINICAL PRACTICE: This study highlights the importance of a dedicated end of treatment visit with the clinical nurse specialist to confirm the completion of active treatment with lymphoma patients and focus on health promotion.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; haematology; lymphoma; qualitative; survivorship

Mesh:

Year:  2018        PMID: 30178544     DOI: 10.1111/jocn.14658

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  7 in total

1.  A virtual resiliency program for lymphoma survivors: helping survivors cope with post-treatment challenges.

Authors:  Giselle K Perez; Emily A Walsh; Kit Quain; Jeremy S Abramson; Elyse R Park
Journal:  Psychol Health       Date:  2020-11-28

2.  Still lost in transition: a qualitative descriptive study of people's experiences following treatment completion for haematological cancer in Wales, UK.

Authors:  Tessa E Watts; Janet Bower
Journal:  Ecancermedicalscience       Date:  2019-12-12

3.  Lymphoma survivors' experience of participation in a home-based intervention post-chemotherapy.

Authors:  Suchita Hathiramani; R Pettengell; H Moir; A Younis
Journal:  Qual Life Res       Date:  2019-07-04       Impact factor: 4.147

4.  'You're kind of left to your own devices': a qualitative focus group study of patients with breast, prostate or blood cancer at a hospital in the South West of England, exploring their engagement with exercise and physical activity during cancer treatment and in the months following standard care.

Authors:  Sian Karen Smith; Gareth Wiltshire; Frankie F Brown; Haryana Dhillon; Mike Osborn; Sarah Wexler; Mark Beresford; Mark A Tooley; James E Turner
Journal:  BMJ Open       Date:  2022-03-28       Impact factor: 2.692

5.  Living with or beyond lymphoma: A rapid review of the unmet needs of lymphoma survivors.

Authors:  Vanessa Boland; Amanda Drury; Greg Sheaf; Anne-Marie Brady
Journal:  Psychooncology       Date:  2022-06-27       Impact factor: 3.955

6.  Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey.

Authors:  Gisèle Compaci; Cécile Conte; Lucie Oberic; Loïc Ysebaert; Guy Laurent; Fabien Despas
Journal:  BMC Cancer       Date:  2019-12-03       Impact factor: 4.430

7.  Relaxation versus exercise for improved quality of life in lymphoma survivors-a randomised controlled trial.

Authors:  Suchita Hathiramani; R Pettengell; H Moir; A Younis
Journal:  J Cancer Surviv       Date:  2020-09-28       Impact factor: 4.442

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.